Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-24-000065

Chief Financial Officer sold 8,637 shares at $19.98 ($172,562)

  • Chief Financial Officer acquired 6,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
WENTWORTH KORY JAMES Chief Financial Officer 2024-11-11 Option exercise 10b5-1 +6,000 $2.10 $12,600 82,486 D
WENTWORTH KORY JAMES Chief Financial Officer 2024-11-11 Sale 10b5-1 −8,637 $19.98 $172,562 73,849 D
Derivatives
WENTWORTH KORY JAMES Chief Financial Officer 2024-11-11 Option exercise · Stock Option (Right to Buy) 10b5-1 −6,000 37,157 D
Open-market sales · 8,637 sh · avg $19.98 · $172,562
Loading xslF345X05/wk-form4_1731534419.xml…